30 Day Trial


Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.


  • 2:45 p.m. NuVasive reported 1Q17 revenue of US $249.9MM, +16.2% vs. 1Q16. (U.S. $214.2MM, +13.7%; ex-U.S. $35.6MM, +33.3%)
  • SpinalCyte was issued Australian Patent No. 2013299505, “Generation of Cartilage Ex Vivo from Fibroblasts.”
  • 12:30 p.m. Orthopaedic product revenue in 2016 surpassed US $48.1BB worldwide, up $1.5BB or +3.2% vs. 2015, per THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®.
Read More

Articles of Interest All Articles

Growth in Joint Recon Returns to the Leading Orthopaedic Companies

Combined, the top five performers grew their orthopaedic revenue by $671.7 million in 2016, +2.4% from 2015. Of that growth, joint recon revenue accounts for $371.1MM…that’s 55% of that $671.7MM, underscoring the fact that if joint recon isn’t growing, these companies face significant obstacles.